[1]
Richard A Lawhern and Pat Irving RN 2025. The FDA is Talking When They Should Be Listening – Part 2: Review Article. American Journal of Medical and Clinical Research & Reviews. 4, 9 (Sep. 2025), 1–3. DOI:https://doi.org/10.58372/2835-6276.1333.